Full Text (PDF)
Case Report

Cervical Cancer

Simrat Kaur, Ritu null

Author Information

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Indian Journal of Cancer Education and Research 11(2):p 79-81, July-December 2023. | DOI: https://doi.org/10.21088/ijcer.2321.9815.11223.4

How Cite This Article:

Ritu, Simrat Kaur/Cervical Cancer/Indian J Canc Educ Res 2023;11(2):-79-81.

Timeline

Received : September 09, 2023         Accepted : December 05, 2023          Published : December 25, 2023

Abstract

Cervical most cancers is a type of most cancers that occurs within the cells of the cervix the decrease a part of the uterus that connects to the vagina numerous strains of the human papillomavirus (HPV), a sexually transmitted infection, play a position in inflicting maximum cervical most cancers while uncovered to HPV, the body's immune system commonly prevents the virus from doing harm. In a small percent of human beings, but, the virus survives for years, contributing to the process that causes some cervical cells to emerge as cancer cells. you may lessen your chance of developing cervical most cancers by having screening assessments and receiving a vaccine that protects against HPV infection.


References

  • 1.   Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021:71:209–49. doi:10.3322/caac.21660.
  • 2.   Stelzle D, Tanaka LF, Lee KK, et al. Estimates of the global burden of cervical cancer associated with HIV. Lancet Glob Health 2020; published online Nov 16. DOI:S2214-109X(20)30459-9.
  • 3.   Lei et al. (2020) HPV Vaccination and the Risk of Invasive Cervical Cancer. N Engl J Med 2020;383:1340-8. DOI: 10.1056/NEJMoa1917338.
  • 4.   Global strategy to accelerate the elimination of cervical cancer as a public health problem.
  • 5.   countrywide comprehensive cancer community (NCCN): NCCN scientific exercise pointers in Oncology: Cervical most cancers. version 1.2022. October 26, 2021. Accessed 6/21/22.
  • 6.   Sedlis A, Bundy BN, Rotman MZ, et al: A randomized trial of pelvic radiation remedy versus no in addition therapy in selected sufferers with level IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology organization have a look at. GynecolOncol 73 (2):177–183, 1999. doi: 10.1006/gyno.1999.5387 three. Rotman M, Sedlis A, Piedmonte MR, et al.: A section III randomized trial of postoperative pelvic irradiation in stage IB cervical carcinoma with terrible prognostic functions: comply with-up of a Gynecologic Oncology organization look et at. Int J Radiat Oncol Biol Phys 65 (1):169–176, 2006. doi: 10.1016/j.ijrobp.2005.10.019 Epub 2006 Jan 19.
  • 7.   Peters WA, Liu PY, Barrett RJ, et al.: Concurrent chemotherapy and pelvic radiation therapy in comparison with pelvic radiation remedy on my own as adjuvant remedy after radical surgical procedure in high-chance early-stage cancer of the cervix. J Clin Oncol 18 (8):1606–1613, 2000. doi: 10.1200/JCO.2000.18.8.1606 five. Monk BJ, Wang J, Im S, et al.: Rethinking the use of radiation and chemotherapy after radical hysterectomy: a scientific-pathologic evaluation of a Gynecologic Oncology institution/Southwest Oncology group/Radiation remedy Oncology organization trial. GynecolOncol 96 (three):721–728, 2005. doi: 10.1016/j.ygyno.2004.eleven.007.
  • 8.   Querleu D, Morrow CP: type of radical hysterectomy. Lancet Oncol nine (three):297–303, 2008. doi: 10.1016/S1470-2045(08)70074-3.
  • 9.   Ramirez PT, Frumovitz M, Pareja R, et al: Minimally invasive as opposed to belly radical hysterectomy for cervical cancer. N Engl J Med 379 (20): 1895–1904, 2018. doi: 10.1056/ NEJMoa1806395.
  • 10.   Cibula D, Dostalek L, Hillemanns P, et al.: crowning glory of radical hysterectomy does now not enhance survival of sufferers with cervical most cancers and intraoperatively detected lymph node involvement: ABRAX global retrospective cohort observe. Eur J most cancers 143:88–100, 2021. doi: 10.1016/j.ejca.2020.10.037 Epub 2020 Dec five.
  • 11.   Marnitz S, Tsunoda AT, Martus P, et al: Surgical as opposed to clinical staging previous to number one chemoradiation in patients with cervical most cancers FIGO degrees IIB–IVA: Oncologic effects of a prospective randomized international multicenter (Uterus-eleven) intergroup examine. Int J Gynecol cancer 30:1855–1861, 2020. doi:10.1136/ijgc-2020-001973.

Data Sharing Statement

There are no additional data available. All raw data and code are available upon request.

Funding

This research received no funding.

Author Contributions

All authors contributed significantly to the work and approve its publication.

Ethics Declaration

This article does not involve any human or animal subjects, and therefore does not require ethics approval.

Acknowledgements

We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.

Conflicts of Interest

No conflicts of interest in this work.


About this article


Cite this article

Ritu, Simrat Kaur/Cervical Cancer/Indian J Canc Educ Res 2023;11(2):-79-81.


Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Received Accepted Published
September 09, 2023 December 05, 2023 December 25, 2023

DOI: https://doi.org/10.21088/ijcer.2321.9815.11223.4

Keywords

CancerSTICervix BenignCellHPV

Article Level Metrics

Last Updated

Monday 23 November 2026, 03:40:44 (IST)


2738

Accesses

9
445
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received September 09, 2023
Accepted December 05, 2023
Published December 25, 2023

licence


Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Access this article



Share